Assignee
KANCERA AB
SE·12 granted patents·3 pending applications·9 citations·filing 2012–2025
Top patents by PatentIndex Score
15 records- 0191US11691988B2Process for the stereoselective preparation of chiral 2-[(hetero)arylalkylsulfanyl]pyrimidines and products obtainable therefromKANCERA AB·Filed 2022·Granted Jul 4, 2023·2 cites·18 claims
- 0291US11339183B2Phosphate and phosphonate derivatives of 7-amino-5-thio-thiazolo[4,5-d]pyrimidines and their use in treating conditions associated with elevated levels of CX3CR1 and/or CX3CL1KANCERA AB·Filed 2021·Granted May 24, 2022·2 cites·17 claims
- 0382US12264165B2Process for the stereoselective preparation of chiral 2-[(hetero) arylalkylsulfanyl]pyrimidines and products obtainable therefromKANCERA AB·Filed 2023·Granted Apr 1, 2025·0 cites·4 claims
- 0481US10654814B2Bicyclic hydroxamic acids useful as inhibitors of mammalian histone deacetylase activityKANCERA AB·Filed 2016·Granted May 19, 2020·5 cites·16 claims
- 0573US2025195549A1New useKANCERA AB·Filed 2024·Application pending·0 cites
- 0672US2025195548A1New useKANCERA AB·Filed 2024·Application pending·0 cites
- 0771US2025230170A1Process for the Steroselective Preparation of Chiral 2-[(Hetero)Arylalkylsulfanyl]Pyrimidines and Products Obtainable TherefromKANCERA AB·Filed 2025·Application pending·0 cites
- 0867US11542281B2Process for the steroselective preparation of chiral 2- [(hetero)arylalkylsulfanyl] pyrimidines and products obtainable therefromKANCERA AB·Filed 2019·Granted Jan 3, 2023·0 cites·23 claims
- 0964US12060380B2Phosphate and phosphonate derivatives of 7-amino-5-thio-thiazolo[4,5-d]pyrimidines and their use in treating conditions associated with elevated levels of CX3CR1 and/or CX3CL1KANCERA AB·Filed 2019·Granted Aug 13, 2024·0 cites·47 claims
- 1051US11660303B22-phenylimidazo[4,5-b]pyridin-7-amine derivates useful as inhibitors of mammalian tyrosine kinase ROR1 activityKANCERA AB·Filed 2021·Granted May 30, 2023·0 cites·20 claims
- 1138US11008318B22-phenylimidazo[4,5-b]pyridin-7-amine derivates useful as inhibitors of mammalian tyrosine kinase ROR1 activityKANCERA AB·Filed 2017·Granted May 18, 2021·0 cites·20 claims
- 1234US9718809B2Bisarylsulfonamides useful in the treatment of inflammation and cancerKANCERA AB·Filed 2012·Granted Aug 1, 2017·0 cites·21 claims
- 1332US10550113B22-phenyl-3H-imidazo[4,5-B]pyridine derivates useful as inhibitors of mammalian tyrosine kinase ROR1 activityKANCERA AB·Filed 2016·Granted Feb 4, 2020·0 cites·17 claims
- 1432US10512634B2Benzimidazole derivates useful as inhibitors of mammalian histone deacetylase activityKANCERA AB·Filed 2015·Granted Dec 24, 2019·0 cites·17 claims
- 1527US10000449B2Bisarylsulfonamides useful in the treatment of inflammation and cancerKANCERA AB·Filed 2016·Granted Jun 19, 2018·0 cites·23 claims
Join the waitlist — get patent alerts
Get an alert when KANCERA AB files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →